These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34388239)

  • 1. Sustained Use of the Impella 5.0 Heart Pump Enables Bridge to Clinical Decisions in 34 Patients.
    Nelson DW; Sundararajan S; Klein E; Joyce LD; Durham LA; Joyce DL; Mohammed AA
    Tex Heart Inst J; 2021 Jul; 48(3):. PubMed ID: 34388239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device.
    Lima B; Kale P; Gonzalez-Stawinski GV; Kuiper JJ; Carey S; Hall SA
    Am J Cardiol; 2016 May; 117(10):1622-1628. PubMed ID: 27061705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical outcomes of bridge-to-bridge therapy with extracorporeal left ventricular assist device for acute myocardial infarction in cardiogenic shock.
    Tokunaga C; Iguchi A; Nakajima H; Chubachi F; Hori Y; Takazawa A; Hayashi J; Asakura T; Yoshitake A
    BMC Cardiovasc Disord; 2022 Feb; 22(1):54. PubMed ID: 35172726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of Impella Microaxial Devices Used to Salvage Cardiogenic Shock as a Bridge to Durable Circulatory Support or Cardiac Transplantation.
    Cheng R; Tank R; Ramzy D; Azarbal B; Chung J; Esmailian F; Kobashigawa JA; Moriguchi JD; Arabia FA
    ASAIO J; 2019; 65(7):642-648. PubMed ID: 30281541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.
    Lemaire A; Anderson MB; Lee LY; Scholz P; Prendergast T; Goodman A; Lozano AM; Spotnitz A; Batsides G
    Ann Thorac Surg; 2014 Jan; 97(1):133-8. PubMed ID: 24090575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First in man evaluation of a novel circulatory support device: Early experience with the Impella 5.5 after CE mark approval in Germany.
    Bernhardt AM; Potapov E; Schibilsky D; Ruhparwar A; Tschöpe C; Spillmann F; Benk C; Schmack B; Schmitto JD; Napp LC; Mayer-Wingert N; Doll N; Reichenspurner H; Schulte-Eistrup S
    J Heart Lung Transplant; 2021 Aug; 40(8):850-855. PubMed ID: 34030970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impella 5.0 therapy as a bridge-to-decision option for patients on extracorporeal life support with unclear neurological outcomes.
    Bernhardt AM; Zipfel S; Reiter B; Hakmi S; Castro L; Söffker G; Kluge S; Lubos E; Rybczinski M; Grahn H; Schrage B; Becher PM; Barten MJ; Westermann D; Blankenberg S; Reichenspurner H
    Eur J Cardiothorac Surg; 2019 Dec; 56(6):1031-1036. PubMed ID: 31038672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of the impella device for acute mechanical circulatory support.
    Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G
    Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of patients with right ventricular failure requiring short-term hemodynamic support with the Impella RP device.
    Anderson M; Morris DL; Tang D; Batsides G; Kirtane A; Hanson I; Meraj P; Kapur NK; O'Neill W
    J Heart Lung Transplant; 2018 Dec; 37(12):1448-1458. PubMed ID: 30241890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock.
    Tarabichi S; Ikegami H; Russo MJ; Lee LY; Lemaire A
    J Cardiothorac Surg; 2020 Aug; 15(1):218. PubMed ID: 32795321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
    Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant implantation of Impella
    Pappalardo F; Schulte C; Pieri M; Schrage B; Contri R; Soeffker G; Greco T; Lembo R; Müllerleile K; Colombo A; Sydow K; De Bonis M; Wagner F; Reichenspurner H; Blankenberg S; Zangrillo A; Westermann D
    Eur J Heart Fail; 2017 Mar; 19(3):404-412. PubMed ID: 27709750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Indications of IMPELLA Short-Term Mechanical Circulatory Support in a Tertiary Centre.
    Monteagudo Vela M; Simon A; Riesgo Gil F; Rosenberg A; Dalby M; Kabir T; García Saez D; Panoulas V
    Cardiovasc Revasc Med; 2020 May; 21(5):629-637. PubMed ID: 31859100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Device profile of the Impella 5.0 and 5.5 system for mechanical circulatory support for patients with cardiogenic shock: overview of its safety and efficacy.
    Pahuja M; Hernandez-Montfort J; Whitehead EH; Kawabori M; Kapur NK
    Expert Rev Med Devices; 2022 Jan; 19(1):1-10. PubMed ID: 34894975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge).
    Gregoric ID; Jacob LP; La Francesca S; Bruckner BA; Cohn WE; Loyalka P; Kar B; Frazier OH
    Tex Heart Inst J; 2008; 35(2):125-9. PubMed ID: 18612448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microaxial devices for ventricular failure: a multicentre, population-based experience.
    Higgins J; Lamarche Y; Kaan A; Stevens LM; Cheung A
    Can J Cardiol; 2011; 27(6):725-30. PubMed ID: 21983112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined pulmonary and left ventricular support with veno-pulmonary ECMO and impella 5.0 for cardiogenic shock after coronary surgery.
    Sayed S; Schimmer C; Shade I; Leyh R; Aleksic I
    J Cardiothorac Surg; 2017 May; 12(1):38. PubMed ID: 28532425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Impella 5.0 and extracorporeal left ventricular assist device in patients with cardiogenic shock.
    Kondo T; Morimoto R; Mutsuga M; Fujimoto K; Okumura T; Shibata N; Kazama S; Kimira Y; Oishi H; Kuwayama T; Hiraiwa H; Usui A; Murohara T
    Int J Artif Organs; 2021 Nov; 44(11):846-853. PubMed ID: 34488481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.